Blue Water Biotech Analyst Ratings
HC Wainwright Adjusts Price Target on Blue Water Biotech to $9 From $7, Maintains Buy Rating
HC Wainwright & Co. Maintains Buy on Blue Water Biotech, Raises Price Target to $9
Maxim Group Remains a Buy on Blue Water Vaccines, Inc. (BWV)
Maxim Group Keeps Their Buy Rating on Blue Water Vaccines, Inc. (BWV)
Blue Water Vaccines Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Blue Water Vaccines, Maintains $7 Price Target
Blue Water Vaccines, Inc. (BWV) Gets a Buy From H.C. Wainwright
Blue Water Vaccines Analyst Ratings
HC Wainwright & Co. Initiates Coverage On Blue Water Vaccines With Buy Rating, Announces Price Target of $7
Blue Water Vaccines Analyst Ratings
Maxim Group Initiates Coverage On Blue Water Vaccines With Buy Rating, Announces Price Target of $4
No Data
No Data